Vivid S60N, Vivid S70N
by Ge Medical System Ultrasound and Primary Care Diagnostics
510(k) K223832
Active
Valid until
No expiry
FDA recalls
2 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK223832 | Date16 Feb 2023 | StatusActive |
Recalls
-
- Ongoing Z-2127-2023
- Ongoing Z-2126-2023
GE HealthCare has become aware that certain Vivid ultrasound systems cannot boot up in a timely fashion. If this occurs, it can delay availability of the device in time-critical emergency situations.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- IYN
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1550
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Vivid S60N and Vivid S70N are portable ultrasound systems designed for advanced cardiac and general imaging. These devices provide high-resolution imaging, automated measurements, and enhanced visualization tools to support precise diagnostic assessments of cardiac function, valve dynamics, and other soft-tissue structures.
The systems are intended for use in clinical settings such as radiology departments and cardiac care units. Supplied sterile or non-sterile as specified by the facility, they may be reusable or single-use depending on institutional protocols. Both models comply with FDA 510(k) clearance under the Radiology Advisory Committee and are classified under product code IYN. Storage and handling follow standard ultrasound system guidelines to maintain performance and safety.
Questions
AI-generated answers, 19 Sep 2026
What are the primary clinical applications for the Vivid S60N and Vivid S70N ultrasound systems, and how do they support diagnostic assessments?
The Vivid S60N and Vivid S70N are specifically designed for advanced cardiac and general imaging. They offer high-resolution imaging, automated measurements, and enhanced visualization tools to help clinicians assess cardiac function, valve dynamics, and soft-tissue structures with precision. These features make them particularly useful in radiology departments and cardiac care units for detailed diagnostic evaluations.
Are the Vivid S60N and Vivid S70N systems intended for sterile use, and how should they be handled in a clinical setting?
The Vivid S60N and Vivid S70N systems are not inherently sterile or non-sterile by design—they can be used in either configuration based on facility protocols. Sterility or reuse depends on institutional policies, as these systems are versatile enough to accommodate both single-use and reusable workflows in clinical settings like radiology or cardiac care units.
What regulatory pathway did the Vivid S60N and Vivid S70N follow to gain market authorization, and which committee reviewed their submission?
The Vivid S60N and Vivid S70N received FDA clearance through a 510(k) submission, classified as *Substantially Equivalent* under the Radiology Advisory Committee (RA). The submission was reviewed under product code IYN, and the decision was made by the Radiology (RA) Review Panel in February 2023.
How do the Vivid S60N and Vivid S70N differ in terms of their intended clinical environments or workflows?
While both models are portable ultrasound systems for cardiac and general imaging, their primary distinction lies in their advanced imaging capabilities—such as high-resolution visualization and automated measurements—which are optimized for clinical settings like radiology departments and cardiac care units. The choice between the S60N and S70N would depend on specific institutional needs for imaging performance rather than a fundamental difference in intended use.